Press coverage about Imaging Canada Liquidating Corp (NASDAQ:IMRS) has trended positive on Monday, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imaging Canada Liquidating Corp earned a media sentiment score of 0.49 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 48.4358226837989 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Shares of Imaging Canada Liquidating Corp (NASDAQ:IMRS) opened at 0.649 on Monday. The stock has a 50 day moving average of $0.55 and a 200 day moving average of $0.67. Imaging Canada Liquidating Corp has a 1-year low of $0.02 and a 1-year high of $1.33.

TRADEMARK VIOLATION WARNING: “Imaging Canada Liquidating Corp (IMRS) Receiving Positive Press Coverage, Report Shows” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at

Imaging Canada Liquidating Corp Company Profile

Imaging Canada Liquidating Corp, formerly IMRIS Inc (IMRIS), is a Canada-based company, which designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and precision in treatment.

Receive News & Stock Ratings for Imaging Canada Liquidating Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imaging Canada Liquidating Corp and related stocks with our FREE daily email newsletter.